Tara Strutt, a researcher with the College of Medicine at UCF, has developed a new immunotherapy treatment for acute respiratory viral infections. These include illnesses such as the flu, pneumonia, RSV, and coronavirus. Strutt’s treatment uses proteins known as cytokines to target the infections.

According to the World Health Organization, these infections are widespread, with the flu causing 3 to 5 million severe cases of illnesses and up to 650,000 deaths every year.  “Interventions that can improve the outcome of serious viral infection without interfering with effective anti-viral immune responses are urgently needed,” said Strutt.

• Tara Strutt